The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Coenzyme Q 10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects
Open accessAbstract
Coenzyme Q 10 is an essential cofactor of the electron transport chain as well as a potent free radical scavenger in lipid and mitochondrial membranes. Feeding with coenzyme Q 10 increased cerebral cortex concentrations in 12- and 24-month-old rats. In 12-month-old rats administration of coenzyme Q 10 resulted in significant increases in cerebral cortex mitochondrial concentrations of coenzyme Q 10 . Oral administration of coenzyme Q 10 markedly attenuated striatal lesions produced by systemic administration of 3-nitropropionic acid and significantly increased life span in a transgenic mouse model of familial amyotrophic lateral sclerosis. These results show that oral administration of coenzyme Q 10 increases both brain and brain mitochondrial concentrations. They provide further evidence that coenzyme Q 10 can exert neuroprotective effects that might be useful in the treatment of neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We also demonstrated that CoQ10 produces neuroprotective effects in transgenic mouse models of ALS and HD150, 151.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [150]
In the citing paper
“Oral administration of CoQ10 exerts significant neuroprotective effects against striatal lesions in rats produced by aminoxyacetic acid, and the mitochondrial toxins malonate and 3-NP148-150.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [150]
In the citing paper
“Similarly, oral administration of CoQ10 for 1 week, prior to administration of 3-NP resulted in a significant 90% neuroprotection against 3-NP induced striatal lesions150.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [150]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Wong, P. C., Pardo, C. A., Borchelt, D., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,439
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,434
Self-citationBruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Biochemical, physiological and medical aspects of ubiquinone function
Ernster, L., & Dallner, G. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00028-3 · Cited by 1,246
Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 962
Self-citationGurney, M. E., Cutting, F. B., Zhai, P., Doble, A., Taylor, C. P., Andrus, P. K., & Hall, E. D. (1996) · Annals of Neurology · doi:10.1002/ana.410390203 · Cited by 647
Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations.
Frei, B. B., Kim, M. C., & Ames, B. N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4879 · Cited by 623
Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease
Mutisya, E. M., Bowling, A. C., & Beal, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062179.x · Cited by 531
Self-citation
Flagged first, then by citations
Research works printed but not linked: 6
- S Sugiyama, K Yamada, T Ozawa Biochem Mol Biol Int 37, 1111–1120 (1995).
- A Sanbe, K Tanonaka, Y Niwano, S Takeo J Pharmacol Exp Ther 269, 51–56 (1994).
- S Takeo, K Tanonaka, T Tazuma, K Miyake, R Murai J Pharmacol Exp Ther 243, 1131–1138 (1987).
- T Nakamura, H Sanma, M Himeno, K Kato Transfer of Exogenous Coenzyme Q to Inner Membrane of Heart Mitochondria in Rats, eds Y Yamamura, K Folkers, Y Ito (Elsevier, Amsterdam) 2, 3–11 (1989).
- V Valls, C Castelluccio, R Fato, M L Genova, C Bovina, G Saez, M Marchetti, P Castelli, G Lenaz Biochem Mol Biol Int 33, 633–642 (1994).
- S Reahal, J Wrigglesworth Drug Metab Dispos 20, 423–427 (1992).
Cited by
Sorted by citations
Items 401–500 of 556
Coenzyme Q10 in Heart and Brain Diseases
Fedačko, J. (2011) · The Open Nutraceuticals Journal · doi:10.2174/1876396001104010069 · Cited by 14
LI, F. C. H., Tseng, H., & Chang, A. Y. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.048 · Cited by 14
Programming Saposin-Mediated Compensatory Metabolic Sinks for Enhanced Ubiquinone Production
Xu, W., Yuan, J., Yang, S., Ching, C., & Liu, J. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00148 · Cited by 14
Nutraceuticals and Behavioral Therapy for Headache
Barmherzig, R., & Rajapakse, T. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01120-3 · Cited by 13
Wu, Y.-L., Chang, J.-C., Sun, H.-L., Cheng, W.-L., Yen, Y.-P., Lin, Y., Chao, Y.-C., Liu, K.-H., Huang, C.-S., Liu, K.-L., et al. (2022) · Nutrients · doi:10.3390/nu14173593 · Cited by 12
Chromosomal Engineering of Escherichia coli for Efficient Production of Coenzyme Q10
Huang, M., Chen, Y., & Liu, J.-Z. (2014) · Chinese Journal of Chemical Engineering · doi:10.1016/s1004-9541(14)60082-3 · Cited by 13
Antioxidant properties of phenols against superoxide radicals
Veliká, B., & Kron, I. (2013) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-013-1008-5 · Cited by 13
Asif, M., & Singh, A. (2016) · Open Pharmaceutical Sciences Journal · doi:10.2174/1874844901603010196 · Cited by 13
Watanabe, K., Nozaki, S., Goto, M., Kaneko, K., Hayashinaka, E., Irie, S., Nishiyama, A., Kasai, K., Fujii, K., Wada, Y., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.073 · Cited by 13
SYNTHESIS OF IDEBENONE; A SYNTHETIC ANALOG OF COENZYME Q
Jung, Y., Joe, B., Seong, C. M., & Park, N. (2001) · Synthetic Communications · doi:10.1081/scc-100105319 · Cited by 13
Koenzym Q10 beim Morbus Parkinson
Storch, A. (2007) · Der Nervenarzt · doi:10.1007/s00115-007-2285-1 · Cited by 13
Frontiñán-Rubio, J., Llanos-González, E., García‐Carpintero, S., Peinado, J. R., Ballesteros‐Yáñez, I., Villar, M., de la Fuente, J., Pérez‐García, V. M., Pérez-Romasanta, L. A., Malumbres, M., et al. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00734-0 · Cited by 12
Oxidative Stress in the Pathogenesis of Neurodegenerative Diseases
Jurcău, M. C., Jurcău, A., & Diaconu, R.-G. (2024) · Stresses · doi:10.3390/stresses4040055 · Cited by 19
Ma, W., Zhao, G., Liu, R., Li, K., Wu, W., Liu, J., He, X., Hou, L., Yu, P., & Mao, L. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202502163 · Cited by 12
Nemtsova, Y., Steinert, B. L., & Wharton, K. A. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103834 · Cited by 12
Majumdar, A., Nirwane, A. M., & Kamble, R. (2014) · Toxicology International · doi:10.4103/0971-6580.139814 · Cited by 12
MINIATURIZED HPLC-UV METHOD FOR ANALYSIS OF COENZYME Q10 IN HUMAN PLASMA
Contin, M. D., Lucangioli, S. E., Martinefski, M., Flor, S. A., & Tripodi, V. P. (2011) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2011.591028 · Cited by 12
Therapeutic Role of Coenzyme Q10 in Brain Injury during Experimental Diabetes
Hussein, J., Abo–Elmatty, D. M., El-Khayat, Z., & Abdel‐Latif, Y. (2013) · Cited by 12
Adams, S. D., Kouzani, A. Z., Tye, S. J., Bennet, K. E., & Berk, M. (2018) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-018-0349-z · Cited by 12
A Diet for Dopaminergic Neurons?
Giovanni, G. D. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_27 · Cited by 12
Neuroprotective possibilities for Huntington’s disease
Emerich, D. F. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.3.467 · Cited by 12
Puoyan‐Majd, S., Parnow, A., Rashno, M., Heidarimoghadam, R., & Komaki, A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230096 · Cited by 11
The Impact of Coenzyme Q10 on Neurodegeneration: a Comprehensive Review
Kadian, M., Sharma, G., Pandita, S., Sharma, K., Shrivasatava, K., Saini, N., & Kumar, A. (2022) · Current Pharmacology Reports · doi:10.1007/s40495-021-00273-6 · Cited by 11
The effect of coenzyme Q10 on venous ischemia reperfusion injury
Özalp, B., Elbey, H., Aydin, H. A., Tekkeşin, M. S., & Uzun, H. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.04.075 · Cited by 11
Shtilbans, A., Reintsch, W., Piscopo, V. E. C., Krahn, A. I., & Durcan, T. M. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1492028 · Cited by 13
Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content
Dhanasekaran, M., Karuppagounder, S. S., Uthayathas, S., Wold, L. E., Parameshwaran, K., Babu, R. J., Suppiramaniam, V. D., & Brown‐Borg, H. M. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.04.016 · Cited by 10
Coenzyme Q10 Does Not Prevent Oral Dyskinesias Induced by Long-Term Haloperidol Treatment of Rats
Andreassen, O. A., Weber, C., & Jørgensen, H. A. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00118-5 · Cited by 10
Evaluation of the Mutagenic and Genotoxic Potential of Ubiquinol
Kitano, M., Mizuhashi, F., Kubo, H., Kishida, H., Fujii, K., Kitahara, M., & Hosoe, K. (2007) · International Journal of Toxicology · doi:10.1080/10915810701707460 · Cited by 10
Mitochondria in neurodegeneration
Beal, M. F. (2002) · Springer eBooks · doi:10.1007/978-2-8178-0929-8_3 · Cited by 10
Self-citationMechanisms and strategies for organ recovery
Andrijević, D., Spajic, A., Hameed, I., Sheth, K. N., Parnia, S., Griesemer, A., Montgomery, R. A., & Šestan, N. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00293-7 · Cited by 10
Tarot, P., Lasbleiz, C., & Liévens, J.-C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385283 · Cited by 9
The plasma membrane redox system in Alzheimer's disease
Adlard, P. A., & Bush, A. I. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.12.009 · Cited by 9
Oral Repeated-Dose Toxicity Studies of Coenzyme Q10 in Beagle Dogs
Yerramilli-Rao, P., Beal, M. F., Watanabe, D., Kieburtz, K. D., de Blieck, E. A., Kitano, M., Hosoe, K., Funahashi, I., & Cudkowicz, M. (2012) · International Journal of Toxicology · doi:10.1177/1091581811425256 · Cited by 9
Self-citationYadav, A., Priyadarshi, A., Keshri, G. K., Verma, S., & Gupta, A. (2021) · Journal of Photochemistry and Photobiology · doi:10.1016/j.jpap.2021.100053 · Cited by 9
Kitwan, L., Makobe, C. K., Mdachi, R. E., Maranga, D. N., Isaac, A. O., & Nyariki, J. N. (2022) · Journal of Parasitic Diseases · doi:10.1007/s12639-022-01553-8 · Cited by 9
Amyotrophic lateral sclerosis – The tools of the trait
Lederer, C. W., & Santama, N. (2007) · Biotechnology Journal · doi:10.1002/biot.200600247 · Cited by 9
Neuroprotective potential of coenzyme Q10
Tripathi, S., Mishra, R., & Singh, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00057-9 · Cited by 9
Simani, L., Rezaei, O., Ryan, F., Sadeghi, M., Hooshmandi, E., Ramezani, M., & Pakdaman, H. (2020) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.11.6.1100.1 · Cited by 8
Nyariki, J. N., Kimani, N. M., Kibet, P. S., Kinuthia, G. K., & Isaac, A. O. (2023) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2023.111579 · Cited by 8
Hammerschmidt, T. G., Donida, B., Raabe, M., Faverzani, J. L., Lopes, F. F., Machado, A. Z., Kessler, R. G., Reinhardt, L. S., Poletto, F. S., Moura, D. J., et al. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01128-9 · Cited by 8
Pradat, P., Attarian, S., Camdessanché, J.-P., Carluer, L., Cintas, P., Corcia, P., Echaniz‐Laguna, A., Gonzalez‐Bermejo, J., Guy, N., Nicolas, G., et al. (2010) · Revue Neurologique · doi:10.1016/j.neurol.2010.03.006 · Cited by 9
Mitochondria and Parkinson's Disease
Simon, D. K., Chu, C. T., & Swerdlow, R. H. (2011) · Parkinson s Disease · doi:10.4061/2011/261791 · Cited by 8
Kawasaki, T. (2012) · The Open Nutraceuticals Journal · doi:10.2174/1876396001205010187 · Cited by 8
El-Laithy, N. A., Mahdy, E.-S. M. E., Youness, E. R., Shafee, N., Mowafy, M. S. S., & Mabrouk, M. M. (2018) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1483 · Cited by 8
Cooper, J. A. D., & Bradley, J. L. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53006-3 · Cited by 8
Exploring antioxidant strategies in the pathogenesis of ALS
Pinilla-González, V., Montecinos-Barrientos, B., Martin-Kommer, C., Chichiarelli, S., Saso, L., & Rodrigo, R. (2024) · Open Life Sciences · doi:10.1515/biol-2022-0842 · Cited by 8
Xu, W., Ma, X., Yao, J., Wang, D., Li, W., Liu, L., Shao, L., & Wang, Y. (2021) · Letters in Applied Microbiology · doi:10.1111/lam.13479 · Cited by 7
Coenzyme Q 10 and the exclusive club of diseases that show a limited response to treatment
Turton, N., Bowers, N. L., Khajeh, S., Hargreaves, I. P., & Heaton, R. A. (2021) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2021.1932459 · Cited by 7
Ouko, D. B., Amwayi, P. W., Ochola, L. A., Wairagu, P. M., Isaac, A. O., & Nyariki, J. N. (2022) · Journal of Parasitic Diseases · doi:10.1007/s12639-022-01468-4 · Cited by 7
Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias
Barca, E., Emmanuele, V., DiMauro, S., Toscano, A., & Quinzii, C. M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171109125643 · Cited by 7
Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases
Cudkowicz, M. E., & Brown, R. H. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-726-0_99 · Cited by 7
Harrison, M., & Singh, S. M. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00544-4 · Cited by 7
Mojaver, A., Khazaei, M., Ahmadpanah, M., Zarei, M., Asl, S. S., Habibi, P., & Shahidi, . (2025) · Neurological Research · doi:10.1080/01616412.2025.2470712 · Cited by 6
Rajput, P., & Krishnamurthy, S. (2022) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2022.107209 · Cited by 6
Diet, Herbs, and Nutritional Protection against Oxidative Stress in Neurological Diseases
Ferrari, C. K. B. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50164-2 · Cited by 6
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Ferro, A., Carbone, E. A., Marzouk, E., Siegel, A., Nguyen, D., Polley, K., Hartman, J., Frederick, K. A., Ives, S. J., & Lagalwar, S. (2017) · Journal of Visualized Experiments · doi:10.3791/53758 · Cited by 6
Saadh, M. J., Saeed, T. N., Al-Hussainy, A. F., Kyada, A., Ballal, S., Kundlas, M., Sabarivani, A., Rizaev, J. A., Taher, S. G., Alwan, M., et al. (2025) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2025.2541698 · Cited by 6
Choudhary, R. C., Shoaib, M., Hayashida, K., Yin, T., Miyara, S. J., d'Abramo, C., Heuser, W., Shinozaki, K., Kim, N., Takegawa, R., et al. (2023) · Cells · doi:10.3390/cells12111548 · Cited by 6
Sangwan, M., Chaudhary, H., Mehan, S., Khan, Z., Bahauddin, A. A., Alrehaili, B. D., Elbadawy, H. M., Almikhlafi, M. A., Narula, A. S., Kalfin, R. E., et al. (2024) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70022 · Cited by 5
The Role of Antioxidant on Health and Age-Related Diseases in Aging
Tan, B. L., & Norhaizan, M. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-82859-2_7 · Cited by 5
Loi, M., Valenti, F., Trazzi, S., Mottolese, N., Candini, G., Bove, A. M., Trebbi, F., Pincigher, L., Fato, R., Bergamini, C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052204 · Cited by 7
Coenzyme Q10 Ameliorates potassium cyanide-induced toxicosis in a mouse model
Gitonga, F., Biwott, K., Gitau, G. W., Okanya, P. W., Amwayi, P. W., Isaac, A. O., & Nyariki, J. N. (2021) · Scientific African · doi:10.1016/j.sciaf.2021.e00815 · Cited by 5
The Effect of Ubiquinol on Cerebral Endothelial Cells in Different Regions of Rat Brain
Shapoval, N. S., Malinovskaya, N. A., Morgun, A. V., Salmina, A. B., Оболенская, О. Н., Na, M., & Os, M. (2021) · Cell and Tissue Biology · doi:10.1134/s1990519x21030111 · Cited by 5
The effects of Coenzyme Q10 on locomotor and behavioral activity in young and aged C57BL/6 mice
Sinatra, D. S., Sinatra, S. T., & Heyser, C. J. (2003) · BioFactors · doi:10.1002/biof.5520180232 · Cited by 5
Mitochondrial Dysfunction in Autistic Children and Oral Coenzyme Q10 Supplementation Treatment
Mousavinejad, E., & Ghaffari, M. A. (2016) · Autism - Open Access · doi:10.4172/2165-7890.1000189 · Cited by 5
Tissue Bioavailability and Detection of Coenzyme Q
Rebrin, I., Kamzalov, S., & Sohal, R. S. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)78009-x · Cited by 5
Giannakou, M., Akrani, I., Tsoka, A., Myrianthopoulos, V., Mikros, E., Vorgias, C. E., & Hatzinikolaou, D. G. (2024) · Pharmaceuticals · doi:10.3390/ph17101286 · Cited by 4
Pan, P., Zhou, N., Sun, Y., Chen, Z., Han, J.-Y., & Zhou, W. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1410133 · Cited by 5
Medical Treatment of Parkinson Disease
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50009-7 · Cited by 4
A Glutamate Scavenging Protocol Combined with Deanna Protocol in SOD1-G93A Mouse Model of ALS
Rogers, C. Q., Ramirez, M., Landon, C. S., DeBlasi, J. M., Koutnik, A. P., Ari, C., & D’Agostino, D. P. (2023) · Nutrients · doi:10.3390/nu15081821 · Cited by 4
Application of Vitamin E + Coenzyme Q Therapy During FAKO + IOL Implantation
Kayiklik, A., & Güvenmez, O. (2019) · Medical Archives · doi:10.5455/medarh.2019.73.109-112 · Cited by 4
A chemogenomic approach is required for effective treatment of amyotrophic lateral sclerosis
Pampalakis, G., Angelis, G., Zingkou, E., Vekrellis, K., & Sotiropoulou, G. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.657 · Cited by 4
Ferroptosis-related stress during aging and its relevance to disease
Maher, P. A., Soriano‐Castell, D., Dar, N. J., Soriano, S., & Currais, A. J. M. (2025) · GeroScience · doi:10.1007/s11357-025-01929-7 · Cited by 6
Contin, M. D., Martinefski, M., Lucangioli, S. E., & Tripodi, V. P. (2011) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 3
Biwott, K., Isaac, A. O., Mwaeni, V. K., Omwenga, G., Ngugi, M. P., & Nyariki, J. N. (2023) · Nutrire · doi:10.1186/s41110-023-00197-9 · Cited by 3
Kollewe, K., Dengler, R., & Petri, S. (2008) · Der Nervenarzt · doi:10.1007/s00115-007-2403-0 · Cited by 3
Naini, A., & Singh, R. B. (2009) · The Open Nutraceuticals Journal · doi:10.2174/1876396000902010013 · Cited by 3
Developments in the treatment of Motor Neurone Disease
Shaw, P. J. (2003) · Cited by 3
Oxidative Stress Reduction (Prong-3)
DePace, N. L., & Colombo, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-17016-5_5 · Cited by 3
Dietary Coenzyme Q10 and Mitochondrial Status
Chow, C. K. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)82007-x · Cited by 3
Novel trends in orphan market drug discovery amyotrophic lateral sclerosis as a case study
Clark, J. E. (2002) · Frontiers in bioscience · doi:10.2741/a762 · Cited by 3
Feasibility of Extracting Solanesol from Tobacco Biomass as a Byproduct Following Protein Recovery
Machado, P. A. (2008) · University Libraries (University of Maryland) · Cited by 3
Neuroprotection becomes reality: changing times for cerebral resuscitation.
Damian, M. S. (2004) · PubMed · Cited by 3
Preclinical testing of potential therapeutics for Amyotrophic Lateral Sclerosis
Kaneb, H. (2012) · Spiral (Imperial College London) · doi:10.25560/9606 · Cited by 3
Altekin, E. (2002) · DergiPark (Istanbul University) · Cited by 2
Coenzyme Q10 Stabilizes Mitochondria in Parkinson’s Disease
Ebadi, M., SHARMA, S. K., Wanpen, S., Shaik, S., & Refaey, H. E. (2005) · Oxidative stress and disease · doi:10.1201/9781420027174.ch12 · Cited by 2
Coenzyme Q and Age-Related Neurodegenerative Disorders: Parkinson and Alzheimer Diseases
Alcain, F. J., Domínguez, J., Durán‐Prado, M., & Vaamonde, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-45642-9_12 · Cited by 2
Persico, A. M., Ricciardello, A., Cucinotta, F., Turriziani, L., Calabrese, G., Tomaiuolo, P., Bella, T. D., Bellomo, F., Boncoddo, M., Turturo, G., et al. (2023) · Rare Disease and Orphan Drugs Journal · doi:10.20517/rdodj.2023.08 · Cited by 2
Nutraceutical’s potentials in neurodegenerative disease
Lohani, A., Maurya, M., Kaur, R., Gaur, A., Khan, S., & Verma, N. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18951-7.00010-4 · Cited by 2
Targeted Delivery of Nutraceuticals Using Nanoparticles
(2016) · Nutraceuticals · doi:10.1201/9781315370859-6 · Cited by 2
Systemic Administration of 3-Nitropropionic Acid
Brouillet, E., Hantraye, P., & Beal, M. F. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_16 · Cited by 2
Self-citationNeuroprotection Becomes Reality
Damian, M. S. (2004) · Advances in experimental medicine and biology · doi:10.1007/978-0-306-48526-8_12 · Cited by 2
Kozin, S. A., Anashkina, A. A., Matsuga, D. G., Suvaan, B. S., Tumanyan, V. G., Mitkevich, V. A., & Makarov, A. А. (2025) · Acta Naturae · doi:10.32607/actanaturae.27630 · Cited by 1
Blood–Brain Barrier and Neuronal Model Systems for Studying CoQ10 Metabolism
Mantle, D., Cufflin, N., Dewsbury, M., & Hargreaves, I. P. (2025) · Antioxidants · doi:10.3390/antiox15010041 · Cited by 1
Castrén, M. L., Westermarck, T., & Atroshi, F. (2014) · InTech eBooks · doi:10.5772/57512 · Cited by 2
Endogenous Antioxidant Mechanisms and Glutamate Neurotoxicity
Farooqui, A. A., Ong, W., & Horrocks, L. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-73023-3_9 · Cited by 1
Comments on Contemporary Methods of Oxygen and Nitrogen Free Radical Detection
(2005) · CRC Press eBooks · doi:10.1201/9781420030853.pt3 · Cited by 1
Reactive Oxygen Species and Atherosclerosis
Víctor, V. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_53 · Cited by 1
Takahashi, H. (2014) · World Journal of Neurology · doi:10.5316/wjn.v4.i1.1 · Cited by 2
Understanding the relationship between oxidative stress and cognition in the elderly
Perry, N., Martin, L., Rosenfeldt, F., Ou, R., Rowsell, R., & Stough, C. K. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820593-8.00006-9 · Cited by 1
Metadata
- Authors
- Matthews, R. T., Yang, L., Browne, S., Baik, M., & Beal, M. F.
- Affiliations
- Harvard University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-07-21
- Volume
- 95
- Issue
- 15
- Pages
- 8892-8897
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC21173
- OpenAlex
- W2100454943
- Cited by
- 557
- References
- 49
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 17 · 2023: 19 · 2022: 19 · 2021: 24 · 2020: 26 · 2019: 18 · 2018: 15 · 2017: 15 · 2016: 16 · 2015: 13 · 2014: 19 · 2013: 22 · 2012: 20
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01ns031579-05)
- National Institute on Aging (P01 AG 12992, P01AG012992)
- National Institute of Neurological Disorders and Stroke (NS 16367, NS31579, P50NS016367)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- coenzyme Q10, cerebral cortex, neuroprotection, 3-nitropropionic acid, striatal lesions, amyotrophic lateral sclerosis, transgenic mouse model, lifespan, neurodegenerative diseases, electron transport chain, free radical scavenging, oral administration
- MeSH terms
- Administration, Oral, Animals, Brain, Coenzymes, Humans, Male, Mice, Transgenic, Mitochondria, Rats, Inbred F344, Superoxide Dismutase, Ubiquinone, Rats, Sprague-Dawley, Neuroprotective Agents, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review